Sarcopenia: An underlying treatment target during the COVID-19 pandemic
Research article
[키워드] 2019 novel coronavirus
acute infection
advanced age
aggravate
anticipated
attacks
benefit
cancers
caused
characterized
chronic disease
conditions
COVID-19
COVID-19 infection
COVID-19 pandemic
disease
Epidemic
immune response
increasingly
infection rate
intensive care
Intervention
modulating
muscle mass
Muscle strength
Muscle wasting
novel coronavirus disease
nutritional deficiency
Patient
physical activity
Population
promote
Protein
protocol
provided
reduced
reported
sarcopenia
SARS-CoV-2
Skeletal muscle
social isolation
Stress
Support
Systematic inflammation
Treatment
[DOI] 10.1016/j.nut.2020.111104 [Article Type] Research article
[DOI] 10.1016/j.nut.2020.111104 [Article Type] Research article